Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ebers, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebers, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 123, No. 11, 2187-2188, November 2000
© 2000 Oxford University Press

Editorial

MRI: measure of efficacy

George Ebers

Action Research professor of Clinical Neurology, Radcliffe Infirmary, University of Oxford, UK

Even the briefest account of progress in the difficult field of adult human demylinating disease would highlight the prominent role played by MRI scanning. The methodology has been prominent in studying disease dynamics and has been applied widely to the evaluation of therapeutic efficacy as epitomized by studies with the type 1 interferons. It has allowed non-invasive identification of objectively measured activity in multiple sclerosis, a disorder notoriously difficult to evaluate. The rationale has been compelling. Enter MRI, and not only could the disease burden of demyelination be computed and the accumulation of new lesions be quantified, but also ongoing activity could be dated by use of contrast enhancing agents.

Near . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
M. Daumer, A. Neuhaus, S. Morrissey, R. Hintzen, and G. C. Ebers
MRI as an outcome in multiple sclerosis clinical trials
Neurology, February 24, 2009; 72(8): 705 - 711.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. H. Miller, A. J. Thompson, and L. Kappos
MRI and assessment of treatment in multiple sclerosis
Brain, May 1, 2001; 124(5): 1052 - 1053.
[Full Text] [PDF]